Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients

Tohoku Journal of Experimental Medicine

Volumn 210, Issue 2, 2006, Pages 109-116

  Yaren, Arzu ^a,e   Turgut, Sebahat ^b   Kursunluoglu, Raziye ^b   Oztop, Ilhan ^c   Turgut, Gunfer ^b   Kelten, Canan ^d   Erdem, Ergun ^b  

^a Department of Internal Medicine   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d Department of Pathology ^*  (Turkey)

^e NONE   (Turkey)

Author keywords

ACE gene polymorphism; Poor prognostic factors; Premenopause breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARTIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GENOMIC DNA; ISOLEUCINE; PROGESTERONE RECEPTOR;

ADULT; ALLELE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE DELETION; GENE INSERTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; TUMOR VOLUME; TURKEY (REPUBLIC);

EID: 33750051613     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.210.109     Document Type: Article

References (33)

1. Abali, H., Gullu, I.H., Engin, H., Haznedaroglu, I.C., Erman, M. & Tekuzman, G. (2002) Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med. Hypotheses, 59, 344-348.
2. Chung, M., Chang, H.R., Bland, K.I. & Wanebo, H.J. (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103.
3. Dabrosin, C. (2005) Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo. Clin. Cancer Res., 11, 8036-8041.
4. DeMichele, A., Martin, A.M., Mick, R.M., Gor, P., Wray, L., Cabral, M.K., Athanasiadis, G., Colligan, T., Stadanauer, E. & Weber, B. (2003) Interleukin 6-174G-C polymorphism is associated with improved outcome in high risk patients. Cancer Res., 63, 8051-8056.
5. Elkhuizen, P.H., van Slooten, H.J., Clahsen, P.C., Hermans, J., van de Velde, C.J., van den Broek, L.C. & van de Vijver, M.J. (2000) High local recurrence risk after breast conserving therapy in node negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J. Clin. Oncol., 18, 1075-1083.
6. Friis, S., Sorensen, H.T., Mellemkjaer, L., McLaughlin, J.K., Nielsen, G.L., Blot, W.J. & Olsen, J.H. (2001) Angiotensin converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer, 92, 2462-2470.
7. Greco, S., Muscella, A., Elia, M.G., Salvatore, P., Storelli, C. & Marsigliante S. (2002) Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. J. Endocrinol., 174, 205-214.
8. Grossman, E., Messerli, F.H. & Goldbourt, U. (2001) Antihypertensive therapy and the risk of malignancies. Eur. Heart. J., 22, 1343-1352.
9. Haiman, C.A., Henderson, S.O., Bretsky, P., Kolonel, L.N. & Henderson, B.E. (2003) Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: The Multiethnic Cohort. Cancer Res., 63, 6984-6987.
10. Hajek, D., Tomiska, M., Krahulcova, E., Druckmuller, M., Florianova, M., Holla, L.I. & Vacha, J. (2003) I/D ACE gene polymorphism in survival of leukemia patients-hypothesis and pilot study. Med. Hypotheses, 61, 80-85.
11. Hii, S.I., Nicol, D.L., Gotley, D.C., Thompson, L.C., Green, M.K. & Jonsson, J.R. (1998) Captopril inhibits tumor growth in xenograft model of human renal cell carcinoma. Br. J. Cancer, 77, 880-883.
12. Hubert, C., Houot, A.M., Corvol, P. & Soubrier, F. (1991) Structure of the angiotensin I-converting enzyme gene: two alternate promoters correspond to evolutionary steps of a duplicated gene. J. Biol. Chem., 266, 15377-15383.
13. Ishitobi, M., Miyoshi, Y., Ando, A., Hasegawa, S., Egawa, C., Tamaki, Y., Monden, M. & Noguchi, S. (2003) Association of BRCA2 polymorphism at codon 784(Met/Val) with breast cancer risk and prognosis. Clin. Cancer Res., 9, 1376-1380.
14. Itoh, H., Mukoyama, M., Pratt, R.E., Gibbons, G.H. & Dzau, V.J. (1993) Multiple growth factors modulate vascular smooth muscle cell response to angiotensin II. J. Clin. Invest., 91, 2268-2273.
15. Jin, Q., Hemminki, K., Enquist, K., Lenner, P., Grzybowska, E., Klaes, R., Henriksson, R., Chen, B., Pamula, J., Pekala, W., Zientek, H., Rogozinska-Szczepka, J., Utracka-Hutka, B., Hallmans, G. & Forsti, A. (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin. Cancer Res., 11, 3647-3653.
16. Koh, W.P., Yuan, J.M., Sun, C.L., van den Berg, D., Seow, A., Lee, H.P. & Yu, M. (2003) Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res., 63, 573-578.
17. Koh, W.P., Yuan, J.M., van den Berg, D., Lee, H.P. & Yu, M.C. (2005) Polymorphism in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis, 26, 459-464.
18. Ladd, A.M.G.Z., Vasquez, A.A., Tabatabaei, F.A.S., Coeberg, J.W., Hofman, A., Njajou, O., Stricker, B. & van Duijin, C. (2005) Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 2143-2146.
19. Le Noble, F.A., Hekking, J.W., van Straaten, H.W., Slaaf, D.W. & Struyker-Boudier, H.A. (1991) Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur. J. Pharmacol., 195, 305-306.
20. Li, C.I., Malone, K.E., Weiss, N.S., Boudreau, D.M., Cushing-Haugen, K.L. & Daling, J.R. (2003) Relation between use of antihypertensive medications and risk of breast carcinoma among women age 65-79 years. Cancer, 98, 1504-1513.
21. Lyall, F., Donran, E.S., McQueen, J., Boswell, F. & Kelly, M. (1992) Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor. J. Hypertens., 10, 1463-1469.
22. Medeiros, R., Vasconcelos, A., Costa, S., Pinto, D., Lobo, F., Morais, A., Oliveira, J. & Lopes, C. (2004) Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J. Pathol., 202, 330-335.
23. Meier, C.R., Derby, L.E., Jick, S.S. & Jick, H. (2000) Angiotensin converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch. Intern. Med., 160, 349-353.
24. Poncz, M., Solowiejczky, D., Harpel, B., Mory, Y., Schwartz, E. & Surrey, S. (1982) Construction of human gene libraries from small amounts of periferal blood. Hemoglobin, 6, 27-36.
25. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. & Soubrier, F. (1990) An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86, 1343-1346.
26. Röcken, C., Lendelkel, U., Dierkes, J., Westphal, S., McGrath, S.C., Peters, B., Kruger, S., Malfertheiner, P., Roessner, A. & Ebert, M.P. (2005) The number of the lymph node metastasis in gastric cancer correlates with the Angiotensin I-converting enzyme gene Insertion/ Deletion polymorphism. Clin. Cancer Res., 11, 2526-2530.
27. Shih, H.A., Couch, F.J., Nathanson, K.L., Blackwood, M.A., Rebbeck, T.R., Armstrong, K.A., Calzone, K., Stopfer, J., Seal, S. & Stratton, M.R. (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J. Clin. Oncol., 20, 994-999.
28. Small, W., Molteni, A., Kim, Y.T., Taylor, J.M., Chen, Z. & Ward, W.F. (1997) Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast Cancer Res. Treat., 44, 217-224.
29. Tomita, S., Deguchi, S., Miyaguni, T., Muto, Y., Tamamoto, T. & Toda, T. (1999) Analyses of microsatellite instability and the transforming growth factor-β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features. Breast Cancer Res. Treat., 53, 33-39.
30. Volpert, O.V., Ward, W.F., Lingen, M.W., Chesler, L., Solt, D.B., Johnson, M.D., Molteni, A., Polverini, P.J. & Bouck, N.P. (1996) Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Invest., 98, 671-679.
31. Yoshiji, H., Kuriyama, S., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatan, T., Tsujinoue, H. & Fukai, H. (2001) The angiotensin converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of vascular endothelial growth factor. Clin. Cancer Res., 7, 1073-1078.
32. Yoshiji, H., Kuriyama, S. & Fukui, H. (2002a) Perindopril: possible use in cancer therapy. Anti-Cancer Drugs, 13, 221-228.
33. Yoshiji, H., Kuriyama, S., Fukui, H. (2002b) Angiotensin-I converting enzyme inhibitors may be an alternative antiangiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumor. Biol., 23, 348-356.